Edition:
India

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

849.75INR
3:59pm IST
Change (% chg)

Rs13.00 (+1.55%)
Prev Close
Rs836.75
Open
Rs833.90
Day's High
Rs851.70
Day's Low
Rs826.00
Volume
2,434,628
Avg. Vol
2,701,904
52-wk High
Rs1,090.00
52-wk Low
Rs723.65

Latest Key Developments (Source: Significant Developments)

Lupin Gets Shareholders' Nod To Reappoint Nilesh Deshbandhu Gupta As MD
Friday, 10 Aug 2018 

Aug 10 (Reuters) - Lupin Ltd ::GETS SHAREHOLDERS' NOD TO REAPPOINT NILESH DESHBANDHU GUPTA AS MD.  Full Article

Lupin Says Mandideep Facility Gets EDQM Approval
Monday, 30 Jul 2018 

July 30 (Reuters) - Lupin Ltd ::SAYS LUPIN'S MANDIDEEP FACILITY GETS APPROVAL FROM EDQM.UNIT WAS INSPECTED BY EUROPEAN DIRECTORATE FOR THE QUALITY OF MEDICINE DURING MARCH 2018.INSPECTION FOCUSED ON APPLICATION FOR CERTIFICATE OF SUITABILITY FOR DOSSIER OF CEFACLOR, FACILITY INSPECTION FOR QUALITY MANAGEMENT SYSTEMS.  Full Article

Lupin Launches Generic Desoximetasone Topical Spray, 0.25 Pct In U.S.
Friday, 27 Jul 2018 

July 27 (Reuters) - Lupin Ltd ::SAYS LUPIN LAUNCHES GENERIC DESOXIMETASONE TOPICAL SPRAY, 0.25 PCT IN US.SAYS DRUG IS INDICATED FOR TREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER.  Full Article

India's Lupin Gets Tentative U.S. FDA Nod For Generic Tadalafil Tablets
Thursday, 19 Jul 2018 

July 19 (Reuters) - Lupin Ltd ::RECEIVES TENTATIVE U.S. FDA APPROVAL FOR GENERIC TADALAFIL TABLETS USP, 2.5 MG, 5 MG, 10 MG, AND 20 MG..  Full Article

India's Lupin Says Goa Facility Gets Approval From UK MHRA
Monday, 16 Jul 2018 

July 16 (Reuters) - Lupin Ltd ::GOA FACILITY GETS APPROVAL FROM UK MHRA..THE UNIT WAS INSPECTED BY UK MHRA IN MARCH 2018 & THERE WERE NO CRITICAL OR MAJOR OBSERVATIONS CITED.  Full Article

Lupin Receives FDA Approval For Generic UTI Drug
Thursday, 12 Jul 2018 

July 12 (Reuters) - Lupin Ltd ::SAYS LUPIN RECEIVES FDA APPROVAL FOR GENERIC NITROFURANTOIN CAPSULES USP (MACROCRYSTALS), 50 MG AND 100 MG.DRUG SPECIFICALLY INDICATED FOR TREATING URINARY TRACT INFECTIONS DUE TO SUSCEPTIBLE STRAINS OF ESCHERICHIA COLI AMONG OTHERS.  Full Article

India's Lupin Gets U.S. FDA Nod For Generic Hydroxychloroquine Sulfate Tablets
Monday, 9 Jul 2018 

July 9 (Reuters) - Lupin Ltd ::GETS FDA APPROVAL FOR GENERIC HYDROXYCHLOROQUINE SULFATE TABLETS USP, 200 MG..CO'S HYDROXYCHLOROQUINE SULFATE TABLETS IS GENERIC VERSION OF CONCORDIA PHARMACEUTICALS' PLAQUENIL TABLETS.  Full Article

Biocon Clarifies Co Retains Economic Interest In Etanercept Collaboration With Mylan
Thursday, 28 Jun 2018 

June 28 (Reuters) - Biocon Ltd ::REFERS TO MYLAN ANNOUNCEMENT OF COMMERCIALIZATION AGREEMENT WITH LUPIN FOR BIOSIMILAR ETANERCEPT FOR CERTAIN MARKETS.CLARIFIES IT RETAINS ITS ECONOMIC INTEREST IN ARRANGEMENT IN ACCORDANCE WITH EXISTING COLLABORATION AGREEMENT WITH MYLAN.  Full Article

Lupin And Mylan Partner To Commercialize Enbrel(Etanercept) Biosimilar
Thursday, 28 Jun 2018 

June 28 (Reuters) - Mylan NV ::LUPIN AND MYLAN PARTNER TO COMMERCIALIZE ENBREL® (ETANERCEPT) BIOSIMILAR.MYLAN- WILL COMMERCIALIZE LUPIN'S PROPOSED ETANERCEPT BIOSIMILAR IN EUROPE, AUSTRALIA, NEW ZEALAND, LATIN AMERICA, AFRICA AND MOST MARKETS THROUGHOUT ASIA.MYLAN - LUPIN WILL RECEIVE AN UP-FRONT PAYMENT OF $15 MILLION AND POTENTIAL COMMERCIAL MILESTONES TOGETHER WITH AN EQUAL SHARE IN NET PROFITS OF PRODUCT..  Full Article

India's Lupin Gets U.S. FDA Nod For Generic Nystatin, Triamcinolone Acetonide Cream
Monday, 4 Jun 2018 

June 4 (Reuters) - Lupin Ltd ::GETS U.S. FDA NOD FOR GENERIC NYSTATIN AND TRIAMCINOLONE ACETONIDE CREAM USP.  Full Article

Photo

India's Lupin first-quarter profit misses estimate by wide margin

Drugmaker Lupin Ltd posted a bigger-than-expected fall in first-quarter profit on Wednesday, hurt by declining sales in the United States and Japan.